Back to Dashboard

D7404C00001 (SOUNDTRACK-B)

Lymphoma•NCT06526793•Last updated: 2/17/2026
Recruiting

Study Design

Study Drug

AZD0486

Mechanism of Action

CD19+CD3 bispecific Ab

Sponsor

Unknown

Design

II

Control Arm

Single-Arm (-)

Criteria

Inclusion Criteria

1. R/R 2. ≥2 prior Tx

Age: Phase: II

Exclusion Criteria

Enrollment

Progress2 / 0

Contact Information

Principal Investigator

Unknown

Study Nurse

李佳玲

Contact Tel

4620